0.24
-2.08%
Close of 9 Nov 2026, in AUD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Compumedics
Its shares trade on ASX under the ticker CMP.AX. It has been listed since 21 December 2000. In the fiscal year to 30 June 2026, it reported revenue of A$60.3m and net income of A$214,000. At that date it held total assets of A$56.6m and shareholders' equity of A$22.7m.
Compumedics Ltd. is engages in the research, development, manufacture and distribution of medical equipment. The company is headquartered in Melbourne, Victoria. The company went IPO on 2000-12-21. Its geographic segments include Americas, Australia and Asia Pacific, and Europe and the Middle East. CMP sells a range of products, including sleep diagnostic systems, clinical EEG systems, brain monitoring systems, ultrasonic blood-flow systems, supplies and technical service and support. CMP’s products include Somfit/Somfit Pro, Grael 4K PSG:EEG, Grael PSG, Somte PSG, Somte, Okti and Siesta 802. CMP’s solution for the neurology laboratory from clinical epilepsy monitoring applications to electromyography diagnostics and transcranial doppler sonography. CMP offers brain research technologies through the Compumedics Neuroscan brand. Compumedics Neuroscan technologies provides solutions for electroencephalogram, ERPs, source localization and functional neuro-imaging.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 21 Dec 2000
- Employees
- 135
- Website
- compumedics.com ↗
Leadership
Pay as last reported
- Dr. David BurtonExecutive Chairman of the Board, Chief Executive Officer, since 2021A$251,108
- Mr. David LawsonChief Financial Officer, Executive Director, Company SecretaryA$387,797
- Mr. Warwick FreemanChief Technology Officer, since 2006A$272,788
- Mr. Christoph WitteGeneral Managing Director - DWL (Compumedics Germany GmbH)A$447,615
- Mr. Rod NorthNon-Executive Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Compumedics Neuroscan provides advanced EEG and neuro-imaging solutions for clinical applications.
- Compumedics offers a diverse product range including Somfit Pro and Grael 4K PSG:EEG systems.
- Compumedics serves key geographic segments like Americas, Australia, and Asia Pacific.
Weaknesses
- Compumedics has 135 employees, which is a small workforce for global operations.
- Compumedics' IPO was in 2000, indicating a long-standing but possibly outdated business model.
- Compumedics' product line includes only medical equipment without broader healthcare services.
Opportunities
- Compumedics can expand its neurology laboratory solutions in the growing Asia Pacific market.
- Compumedics Neuroscan can leverage brain research technologies for new applications.
- Compumedics can enhance its sleep diagnostic systems in the Americas segment.
Threats
- Compumedics faces competition from established medical equipment manufacturers in Europe and the Middle East.
- Compumedics must address potential regulatory changes in the Health Care sector.
- Compumedics' small employee count may limit its ability to scale rapidly.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.